Clinical trial
CBD for Individuals at Risk for Alzheimer's Disease
NCT05822362
Study timeline
Study start (actual)2024-01-19Date precision: day
Registry last updated2026-06-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Mild Cognitive Impairmentunresolved
Interventions
CannabidiolDRUG · verified · RxNorm: cannabidiol
PlaceboOTHER
Sponsors & collaborators
University of Colorado, Denverlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05822362 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.